Lynx1 Capital Management LP Holdings & Portfolio - 13F Filings Analysis - Stocknear

Lynx1 Capital Management LP

CIK Number: 0001910456

346.17M
Market Value
14
# of Holdings
6 months
Avg. Holding Period
Win Rate
Peformance 3-Years

Filing Date: May 15, 2025

Rank Symbol Name Price % Change Shares % Change Shares Market Value Avg. Price Paid % Weight Asset Type
1 GHRS GH Research PLC
12.89
-3.95% 6.44M +32.62% 71.08M 10.05 25.45% Share
2 MRUS Merus N.V.
67.13
-2.07% 1.57M -0.76% 66.03M 36.34 23.65% Share
3 PTGX Protagonist The...
57.74
-1.06% 733.01K +100.00% 35.45M 48.36 12.69% Share
4 STOK Stoke Therapeut...
22.66
+2.67% 5.29M +2.02% 35.19M 8.44 12.60% Share
5 CGEM Cullinan Therap...
6.47
-5.27% 3.22M +155.66% 24.34M 9.95 8.72% Share
6 ALLO Allogene Therap...
1.11
-2.63% 11.06M +1.68% 16.14M 2.4 5.78% Share
7 CCCC C4 Therapeutics...
2.64
-1.49% 7.1M +3.58% 11.36M 4.78 4.07% Share
8 TCRX TScan Therapeut...
1.84
-0.27% 5.36M 0.00% 7.39M 2.51 2.65% Share
9 DTIL Precision BioSc...
4.98
-2.08% 766.05K 0.00% 3.65M 3.81 1.31% Share
10 IBIO iBio, Inc.
0.88
+5.99% 862.28K 0.00% 3.47M 3.01 1.24% Share
11 PASG Passage Bio, In...
7.05
+0.71% 9.26M 0.00% 3.27M 1.04 1.17% Share
12 UPB Upstream Bio, I...
17.80
-2.41% 219.25K -8.66% 1.34M 16.44 0.48% Share
13 NEUP Neuphoria Thera...
13.92
-7.78% 45.81K 0.00% 263.84K 3.43 0.09% Share
14 DSGN Design Therapeu...
6.13
-7.68% 65.95K +100.00% 254.58K 3.86 0.09% Share